Answer
It is licensed to prevent serious RSV lower respiratory tract disease requiring hospitalisation in specified high-risk young children.
Sources for this answer
- Synagis 50 mg/0.5 ml solution for injectionemc · SmPC Current selected SmPC · Version 4